Gender differences in hepatitis C virus incidence in and out of opioid agonist treatment among people who inject drugs in Montréal, Canada, March 2011–March 2024

This publication has 34 references indexed in Scilit:

• Hepatitis C Virus Reinfection Among People Who Inject Drugs
  JAMA Network Open, 2024
• Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis
  eClinicalMedicine, 2024
• Gender, sexual orientation identity, and initiation of amphetamine injecting among people who inject drugs: Examination of an expanding drug era in Montreal, Canada, 2011–19
  Drug and Alcohol Dependence, 2023
• Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020)
  International Journal of Drug Policy, 2022
• A gender lens is needed in hepatitis C elimination research
  International Journal of Drug Policy, 2022
• Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs
  American Journal of Preventive Medicine, 2020
• Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada
  Drug and Alcohol Dependence, 2020
• High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention
  International Journal of Drug Policy, 2017
• The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting
  Drug and Alcohol Dependence, 2017
• Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention
  International Journal of Drug Policy, 2015